PEB - Pacific Edge Ltd

[MAC]

Revenues vs Royalties.

They both start with R I guess...

Very often with biotech agreements, milestone payments are event linked rather than time linked, whilst Pacific Edge and Cellmid haven’t publically offered insight into their contract agreement, the milestone payment may well also be linked to commercialisation progress rather than just as an annualised payment, it would be nice to know.

[Xerof]

The 2014 AR for Cellmid states that a milestone payment of 800k was received from PEB.......triggered by commencement of sales in USA

The 150 million Americans who have secure reimbursement in place relates to the 4 signed up Reimburers

Stand at ease team.....

[psychic]

The 2014 AR for Cellmid states that a milestone payment of 800k was received from PEB.......triggered by commencement of sales in USA

Think I recall this by way of share issue? Didn't Cellmid then sell the shares?

[Xerof]

Think I recall this by way of share issue? Didn't Cellmid then sell the shares?

Yes

Don't know, BUT....

CDY declared a gain from sale of financial assets of ~430k in their AR, so I would guess they have sold out, given they are cash hungry

[Harvey Specter]

Think I recall this by way of share issue? Didn't Cellmid then sell the shares?

They were issued 1m shares at about the time they were worth 60c. That was triggerd by the first sale. I assume after that, they go onto normal royalties rather than further milestone payments. Royalties will be 1.5 ~ 4% depending on which article above you beleive.

[warthog]

Cellmid SP hasn't really moved since the presentation. CxBladder is only one of Cellmid's irons inthe fire, though an important one. The company's CEO was buying up shares on her own account on the open market a couple of weeks ago at about the current level.

Source of this info?

Thank you.

[NT001]

Not sure which info you wanted the source of, but assume it's the last.

http://www.proactiveinvestors.com/co...ase-56945.html

[warthog]

Cheers for that.

[Carpenterjoe]

They were issued 1m shares at about the time they were worth 60c. That was triggerd by the first sale. I assume after that, they go onto normal royalties rather than further milestone payments. Royalties will be 1.5 ~ 4% depending on which article above you beleive.

Further on royalties, I recall from cellmids last report, they are currently between $1and $9.99 per test.

[AndyLP]

Man, Exact Sciences over in the US is getting it right with their bio marker test for Colon Cancer - Cologuard. Official FDA approval, and now Medicare coverage for those who meet the criteria shortly after. Big gains in the SP consequently.
Disc, still holding a good chunk.